Technologies in the News
Technologies in the News
-
HIT Fund Teams Make the Leap to Market
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
Stanford Innovations Behind the Next Generation of Quantum Technology
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
This Prickly Patch Could Deliver Vaccines, Take Samples, and More
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
Stanford-Discovered Molecule Could Underpin New Weight Loss Drugs
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
Stanford Startup Feon Energy Pursues Better Battery Electrolytes
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
Two Stanford Rare Disease Treatments Bring Hope to Patients
From Stanford OTL's Annual Report for Fiscal Year 2025: "Qubits to Clinic"
June 11, 2026
-
Inside the Invention of the Stanford Router That Inspired Cisco
Bill Yeager’s multiprotocol router, invented on campus in 1980, was the basis for Cisco’s first product.
October 08, 2025
-
Illuminating the Immune System with Silicon Photonics
From Stanford OTL's Annual Report for Fiscal Year 2023-2024: "Bridging to Impact"
June 11, 2025
-
Tiny But Bright: High-Performance Lasers Go Chip Scale
From Stanford OTL's Annual Report for Fiscal Year 2023-2024: "Bridging to Impact"
June 11, 2025
-
Secret Sauce: A New Hydrogel for Vaccines, Surgical Recovery, Wildfires, and More
From Stanford OTL's Annual Report for Fiscal Year 2023-2024: "Bridging to Impact"
June 11, 2025
-
Two Steps Forward: New Integrin-Binding Molecule is a ‘Guided Missile’
From Stanford OTL's Annual Report for Fiscal Year 2023-2024: "Bridging to Impact"
June 11, 2025
-
New tool lets scientists observe genome dynamics in real time
A technique to see DNA as it moves in living cells could offer novel fundamental insights into biology.
April 25, 2025
-
DiCE Gets Its 'Library' Card Ready As It Speeds Development Of DNA Database-derived Molecules with More Investor Cash
The DiCE Molecules CEO is plotting a clinical trial launch for the biotech’s lead small molecule for psoriasis and wants to double the staff in the next year and a half.
January 08, 2021
-
A longtime CytomX exec re-emerges at Synthekine, an $82M Stanford spinout
Debanjan Ray apparently had big plans when he quietly left his long-held CFO spot at CytomX back in March 2019. He had gotten his own biotech.
September 17, 2020
-
Jim Broderick reels in a $100M Series B to explore a 'new and big' angle of immune regulation
Palleon Pharmaceuticals announced the completion of a $100 million Series B round to develop its pipeline of glyco-immunology therapies.
September 17, 2020
-
Stanford Medicine scientists hope to use data from wearable devices to predict illness, including COVID-19
Researchers from Stanford Medicine and their collaborators aim to predict the onset of viral infection through data provided by wearable technology.
April 14, 2020
